Mifepristone for the prevention of olanzapine-induced weight gain in rats

被引:0
|
作者
Beebe, KL [1 ]
Block, T [1 ]
DeBattista, C [1 ]
Blasey, C [1 ]
Schatzberg, AF [1 ]
机构
[1] Corcept Therapeut, Clin Res & Dev, Menlo Pk, CA USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:S130 / S130
页数:1
相关论文
共 50 条
  • [11] A parametric analysis of olanzapine-induced weight gain in female rats
    G. D. Cooper
    L. C. Pickavance
    J. P. H. Wilding
    J. C. G. Halford
    A. J. Goudie
    Psychopharmacology, 2005, 181 : 80 - 89
  • [12] Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
    Hu, Yueshan
    Young, Alan J.
    Ehli, Erik A.
    Nowotny, Dustin
    Davies, Paige S.
    Droke, Elizabeth A.
    Soundy, Timothy J.
    Davies, Gareth E.
    PLOS ONE, 2014, 9 (03):
  • [13] Aripiprazole for the Management of Olanzapine-induced Weight Gain
    Englisch, S.
    Weinbrenner, A.
    Inta, D.
    Zink, M.
    PHARMACOPSYCHIATRY, 2009, 42 (04) : 166 - 167
  • [16] The Effect of Ranitidine on Olanzapine-Induced Weight Gain
    Ranjbar, Fatemeh
    Ghanepour, Alireza
    Sadeghi-Bazargani, Homayoun
    Asadlo, Mahbob
    Alizadeh, Amineh
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [17] OLANZAPINE-INDUCED WEIGHT GAIN: DEVELOPING AN ANIMAL MODEL USING MALE RATS
    van der Zwaal, E. M.
    Luijendijk, M. C. M.
    la Fleur, S. E.
    Adan, R. A. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (02) : 213 - 213
  • [18] Olanzapine-induced destabilization of diabetes in the absence of weight gain
    Ramankutty, G
    ACTA PSYCHIATRICA SCANDINAVICA, 2002, 105 (03) : 235 - 236
  • [19] Effect of smoking status on olanzapine-induced weight gain
    Lasser, R
    Gharabawi, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S316 - S316
  • [20] Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats
    Kalinichev, M
    Rourke, C
    Daniels, AJ
    Grizzle, MK
    Britt, CS
    Ignar, DM
    Jones, DNC
    PSYCHOPHARMACOLOGY, 2005, 182 (02) : 220 - 231